What Are The Estimated Market Size And CAGR For The Glaucoma Surgery Devices Market Between 2026 And 2030?
The glaucoma surgery devices market size has grown rapidly in recent years. It will grow from $2.13 billion in 2025 to $2.44 billion in 2026 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to rising prevalence of glaucoma disorders, increased ophthalmic surgical volumes, growing awareness of early glaucoma treatment, expansion of eye care infrastructure, availability of advanced surgical instruments.
The glaucoma surgery devices market size is expected to see rapid growth in the next few years. It will grow to $4.21 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing aging population, rising adoption of MIGS procedures, growing investments in ophthalmic innovation, increasing demand for outpatient eye surgeries, expansion of advanced glaucoma treatment access. Major trends in the forecast period include increasing adoption of minimally invasive glaucoma surgery devices, rising use of micro-invasive glaucoma implants, growing integration of laser-based treatment systems, expansion of personalized glaucoma treatment approaches, enhanced focus on surgical precision and safety.
Claim Your Free Report Sample Today:
What Essential Growth Drivers Are Pushing The Glaucoma Surgery Devices Market Forward?
The growth in the prevalence of glaucoma is expected to boost the growth of the glaucoma surgery devices market. Glaucoma is a progressive eye disease that damages the optic nerve and can lead to permanent vision loss if not diagnosed and treated promptly. Glaucoma surgery devices play a major role in executing glaucoma surgery, and they have made glaucoma surgeries safer, more effective, and less invasive, which significantly contributes to the increasing demand. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2025, over 3 million Americans are affected by glaucoma, and this number is projected to increase to 6.3 million by 2050 due to the aging population in the US. Therefore, the growth in the prevalence of glaucoma will drive the glaucoma surgery devices market forward.
Which Segment Groups Play A Crucial Role In Outlining The Glaucoma Surgery Devices Market’s Structure?
The glaucoma surgery devices market covered in this report is segmented –
1) By Product: Drainage Systems, Laser-Based Devices, Implants
2) By Treatment: Open-Angle, Closed-Angle
3) By Type Of Surgery: Angle Closure Glaucoma Surgery, Aqueous Shunt Surgery, Laser Surgery
4) By Application: Conventional Glaucoma Surgeries, Minimally Invasive Glaucoma Surgeries
5) By End User: Eye Hospitals, Ophthalmology Clinics, Outpatient Surgical Centers
Subsegments:
1) By Drainage Systems: Tubes And Shunts, Valves
2) By Laser-Based Devices: Laser Trabeculoplasty, Laser Iridotomy Devices, Laser Cyclophotocoagulation Devices
3) By Implants: Gel Stents, Ahmed Glaucoma Valve Implants, Baerveldt Implants
Which Trends Are Reshaping Growth Within The Glaucoma Surgery Devices Market?
Major companies operating in the glaucoma surgery devices market are focusing on developing innovative solutions, such as direct selective laser trabeculoplasty (DSLT) devices, to provide precise, non-invasive treatment for lowering intraocular pressure in glaucoma patients. Direct selective laser trabeculoplasty (DSLT) devices are advanced ophthalmic tools that use targeted laser energy to treat the eye’s drainage system, reducing intraocular pressure in glaucoma patients without invasive surgery. For instance, in February 2025, Alcon Inc., a Switzerland-based eye care device company, launched Voyager DSLT, the first and only Direct Selective Laser Trabeculoplasty (DSLT) device for treating glaucoma and ocular hypertension. Voyager DSLT is a fully automated system that delivers 120 laser pulses precisely to the trabecular meshwork via the limbus using advanced eye-tracking technology, without requiring a gonio lens or manual aiming. This innovation enhances aqueous outflow to lower intraocular pressure, simplifying the procedure for physicians while improving patient comfort. By enabling a fast, non-contact, and comfortable treatment, the device is suitable as a first-line therapy, potentially reducing patients’ reliance on medications while maintaining a strong safety profile.
Which Companies Represent The Key Strategic Forces Within The Glaucoma Surgery Devices Market?
Major companies operating in the glaucoma surgery devices market are Alcon, Johnson & Johnson, Carl Zeiss Meditec AG, Bausch & Lomb, Glaukos Corporation, Sight Sciences, Iridex Corporation, Ellex Medical Lasers, Lumenis, Ziemer Ophthalmic Systems, Nidek, Topcon, BVI, Rheon Medical, New World Medical, Haag-Streit, OptoLight Vision Technology, Katalyst Surgical, Aerie Pharmaceuticals, MicroSurgical Technology, iSTAR Medical
Get Your In-Depth Glaucoma Surgery Devices Market Report Now:
What Are The Fastest-Expanding Regions Contributing To The Growth Of The Glaucoma Surgery Devices Market?
North America was the largest region in the glaucoma surgery devices market in 2025. The regions covered in the glaucoma surgery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment